Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries.


Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
30 Jan 2020
Historique:
received: 16 02 2019
accepted: 06 01 2020
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 20 11 2020
Statut: epublish

Résumé

Oligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes. To date, the prevalence of this condition and its outcomes has not been well described in low and low-middle income countries (LMIC) where ultrasound use to diagnose this condition in pregnancy is limited. As part of a prospective trial of ultrasound at antenatal care in LMICs, we sought to evaluate the incidence of and the adverse maternal, fetal and neonatal outcomes associated with oligohydramnios. We included data in this report from all pregnant women in community settings in Guatemala, Pakistan, Zambia and the Democratic Republic of Congo (DRC) who received a third trimester ultrasound as part of the First Look Study, a randomized trial to assess the value of ultrasound at antenatal care. Using these data, we conducted a planned secondary analysis to compare pregnancy outcomes of women with to those without oligohydramnios. Oligohydramnios was defined as measurement of an Amniotic Fluid Index less than 5 cm in at least one ultrasound in the third trimester. The outcomes assessed included maternal morbidity and fetal and neonatal mortality, preterm birth and low-birthweight. We used pairwise site comparisons with Tukey-Kramer adjustment and multivariable logistic models using general estimating equations to account for the correlation of outcomes within cluster. Of 12,940 women enrolled in the clusters in Guatemala, Pakistan, Zambia and the DRC in the First Look Study who had a third trimester ultrasound examination, 87 women were diagnosed with oligohydramnios, equivalent to 0.7% of those studied. Prevalence of detected oligohydramnios varied among study sites; from the lowest of 0.2% in Zambia and the DRC to the highest of 1.5% in Pakistan. Women diagnosed with oligohydramnios had higher rates of hemorrhage, fetal malposition, and cesarean delivery than women without oligohydramnios. We also found unfavorable fetal and neonatal outcomes associated with oligohydramnios including stillbirths (OR 5.16, 95%CI 2.07, 12.85), neonatal deaths < 28 days (OR 3.18, 95% CI 1.18, 8.57), low birth weight (OR 2.10, 95% CI 1.44, 3.07) and preterm births (OR 2.73, 95%CI 1.76, 4.23). The mean birth weight was 162 g less (95% CI -288.6, - 35.9) with oligohydramnios. Oligohydramnos was associated with worse neonatal, fetal and maternal outcomes in LMIC. Further research is needed to assess effective interventions to diagnose and ultimately to reduce poor outcomes in these settings. NCT01990625.

Sections du résumé

BACKGROUND BACKGROUND
Oligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes. To date, the prevalence of this condition and its outcomes has not been well described in low and low-middle income countries (LMIC) where ultrasound use to diagnose this condition in pregnancy is limited. As part of a prospective trial of ultrasound at antenatal care in LMICs, we sought to evaluate the incidence of and the adverse maternal, fetal and neonatal outcomes associated with oligohydramnios.
METHODS METHODS
We included data in this report from all pregnant women in community settings in Guatemala, Pakistan, Zambia and the Democratic Republic of Congo (DRC) who received a third trimester ultrasound as part of the First Look Study, a randomized trial to assess the value of ultrasound at antenatal care. Using these data, we conducted a planned secondary analysis to compare pregnancy outcomes of women with to those without oligohydramnios. Oligohydramnios was defined as measurement of an Amniotic Fluid Index less than 5 cm in at least one ultrasound in the third trimester. The outcomes assessed included maternal morbidity and fetal and neonatal mortality, preterm birth and low-birthweight. We used pairwise site comparisons with Tukey-Kramer adjustment and multivariable logistic models using general estimating equations to account for the correlation of outcomes within cluster.
RESULTS RESULTS
Of 12,940 women enrolled in the clusters in Guatemala, Pakistan, Zambia and the DRC in the First Look Study who had a third trimester ultrasound examination, 87 women were diagnosed with oligohydramnios, equivalent to 0.7% of those studied. Prevalence of detected oligohydramnios varied among study sites; from the lowest of 0.2% in Zambia and the DRC to the highest of 1.5% in Pakistan. Women diagnosed with oligohydramnios had higher rates of hemorrhage, fetal malposition, and cesarean delivery than women without oligohydramnios. We also found unfavorable fetal and neonatal outcomes associated with oligohydramnios including stillbirths (OR 5.16, 95%CI 2.07, 12.85), neonatal deaths < 28 days (OR 3.18, 95% CI 1.18, 8.57), low birth weight (OR 2.10, 95% CI 1.44, 3.07) and preterm births (OR 2.73, 95%CI 1.76, 4.23). The mean birth weight was 162 g less (95% CI -288.6, - 35.9) with oligohydramnios.
CONCLUSIONS CONCLUSIONS
Oligohydramnos was associated with worse neonatal, fetal and maternal outcomes in LMIC. Further research is needed to assess effective interventions to diagnose and ultimately to reduce poor outcomes in these settings.
TRIAL REGISTRATION BACKGROUND
NCT01990625.

Identifiants

pubmed: 32000798
doi: 10.1186/s12978-020-0854-y
pii: 10.1186/s12978-020-0854-y
pmc: PMC6993413
doi:

Banques de données

ClinicalTrials.gov
['NCT01990625']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

19

Subventions

Organisme : NICHD NIH HHS
ID : UG1 HD076461
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD078438
Pays : United States
Organisme : Bill and Melinda Gates Foundation
ID : OPP1056057
Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078438
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076474
Pays : United States

Références

J Coll Physicians Surg Pak. 2007 Jun;17(6):336-9
pubmed: 17623581
Curr Probl Diagn Radiol. 2017 May - Jun;46(3):210-215
pubmed: 28057388
J Perinat Med. 2018 Oct 25;46(8):948-950
pubmed: 29924737
Ultrasound Obstet Gynecol. 2017 Apr;49(4):442-449
pubmed: 27062200
J Matern Fetal Neonatal Med. 2011 Mar;24(3):453-7
pubmed: 20608800
Ultrasound Q. 2014 Dec;30(4):262-6
pubmed: 25415862
PLoS One. 2015 Dec 11;10(12):e0144334
pubmed: 26658482
J Matern Fetal Neonatal Med. 2004 Apr;15(4):233-6
pubmed: 15280130
Reprod Health. 2015;12 Suppl 2:S1
pubmed: 26063166
Glob Health Sci Pract. 2016 Dec 28;4(4):675-683
pubmed: 28031304
Clin Obstet Gynecol. 1997 Jun;40(2):280-9
pubmed: 9199840
J Perinatol. 2002 Jun;22(4):282-5
pubmed: 12032790
Am J Obstet Gynecol. 2011 Sep;205(3):241.e1-6
pubmed: 22071052
BMC Pregnancy Childbirth. 2014 Feb 17;14:73
pubmed: 24533878
BJOG. 2018 Nov;125(12):1591-1599
pubmed: 29782696
BMC Pregnancy Childbirth. 2009 May 07;9 Suppl 1:S5
pubmed: 19426468
Int J Gynaecol Obstet. 2002 Jan;76(1):15-21
pubmed: 11818089

Auteurs

Lester Figueroa (L)

Instituto de Nutrición de Centro América y Panamá (INCAP), Guatemala City, Guatemala.

Elizabeth M McClure (EM)

Social Statistical and Environmental Health Sciences, RTI International, Durham, NC, USA. mcclure@rti.org.

Jonathan Swanson (J)

Department of Radiology, University of Washington Medical Center, Seattle, WA, USA.

Robert Nathan (R)

Department of Radiology, University of Washington Medical Center, Seattle, WA, USA.

Ana L Garces (AL)

Instituto de Nutrición de Centro América y Panamá (INCAP), Guatemala City, Guatemala.

Janet L Moore (JL)

Social Statistical and Environmental Health Sciences, RTI International, Durham, NC, USA.

Nancy F Krebs (NF)

Department of Pediatrics, University of Colorado, Denver, CO, USA.

K Michael Hambidge (KM)

Department of Pediatrics, University of Colorado, Denver, CO, USA.

Melissa Bauserman (M)

Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Adrien Lokangaka (A)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Antoinette Tshefu (A)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Waseem Mirza (W)

Department of Radiology, Aga Khan University, Karachi, Pakistan.

Sarah Saleem (S)

Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.

Farnaz Naqvi (F)

Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.

Waldemar A Carlo (WA)

Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.

Elwyn Chomba (E)

Department of Pediatrics, University of Zambia, Lusaka, Zambia.

Edward A Liechty (EA)

Department of Pediatrics, Indiana University, Indianapolis, IN, USA.

Fabian Esamai (F)

School of Medicine, Moi University, Eldoret, Kenya.

David Swanson (D)

Department of Radiology, Harborview Medical Center, University of Washington Medical Center, Seattle, WA, USA.

Carl L Bose (CL)

Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Robert L Goldenberg (RL)

Department of Obstetrics/Gynecology, Columbia University, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH